Alliance Pharma (LON:APH) Hits New 1-Year Low at $31.00

Alliance Pharma plc (LON:APH)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 31 ($0.39) and last traded at GBX 32 ($0.40), with a volume of 4439000 shares traded. The stock had previously closed at GBX 33.10 ($0.42).

Analysts Set New Price Targets

Separately, Royal Bank of Canada dropped their target price on Alliance Pharma from GBX 65 ($0.82) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research report on Wednesday, January 31st.

Alliance Pharma Stock Down 3.3 %

The firm’s 50 day moving average is GBX 37.59 and its two-hundred day moving average is GBX 38.29. The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.00. The stock has a market cap of £172.93 million, a price-to-earnings ratio of -3,310.00, a P/E/G ratio of 1.04 and a beta of 0.60.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.